Search

Search Results

• The effectiveness of complex therapy in patients with gout using carbon enterosorbent

  Uliana Mudra, Serhiy Andreychyn

  138-147

  2020-07-20
• Endocrine status of adolescent girls with non-alcoholic fatty liver disease and obesity

  E. F. Chaykivska

  434-444

  2020-06-30
• State of plasma hemostasis in patients with hypertension in combination with non-alcoholic fatty liver disease

  N. Bazhenova

  294-303

  2018-10-31
• The analysis of a wide spectrum of activity of Sodium-Glucose co-transporter-2 inhibitors. A literature review

  Magdalena Kozioł, Danuta Krasowska, Marcin Lewicki, Mateusz Pawlicki, Anna Łopuszyńska, Aleksandra Krasa, Ewa Piekarska

  439-449

  2020-08-30
• The state of plasma hemostasis in patients with hypertonic disease and non-alcoholic fat-liver disease under conditions of hypercholesterinemia and associated statinotherapy

  N. M. Bazhenova

  282-291

  2020-11-30
• Role of fatty acids in pathogenetic mechanisms of NAFLD progression among type 2 diabetes patients

  G. Mykhalchyshyn

  254-260

  2020-11-30
• Predictors of NAFLD rapidly progression in type 2 diabetes patients

  G. Mykhalchyshyn

  230-236

  2020-10-30
• Combined influence of polymorphic variants of PPAR-2 (rs1801282) and ACE (rs4646994) genes on the onset of non-alcoholic fatty liver disease in patients with essential arterial hypertension and obesity

  Yu. M. Yarynych, L. P. Sydorchuk

  364-371

  2018-02-26
• Non-alcoholic fatty liver disease after liver transplantation: A lifestyle reloaded

  Lubomir Skladany, Jana Badinkova, Svetlana Adamcova-Selcanova

  116-133

  2017-10-10
• Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

  Magdalena Mazurek, Edyta Białowąs, Ewelina Dybała, Iwona Cuber, Artur Aghadi

  123-131

  2023-02-20
• Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)

  Patrycja Walczak, Klaudia Walczak, Sylwia Zdun, Sylwia Nemeczek, Konrad Merkisz, Jakub Grzybowski, Agnieszka Marciniak, Natalia Grzywna, Karolina Jaskuła, Władysław Orłowski

  58-64

  2023-01-16
• Тhe role of the internal use of mineral water in the complex treatment of patients with chronic viral hepatitis C with concomitant non-alcoholic fatty liver disease

  Anna Izha

  226-235

  2020-01-31
• Рrospects for the use of “dry” carbon dioxide baths in patients with chronic viral hepatitis c with concomitant non-alcoholic fatty liver disease (literature review and own research)

  Anna Izha

  341-349

  2020-06-30
• Patophysiology of nonalcoholic fatty liver disease

  Ewa Krzewicka-Romaniuk, Dagna Siedlecka, Marcelina Makuch, Anna Pradiuch, Grażyna Wójcicka

  987-991

  2019-09-26
• Inactivity and fatty liver disease

  Marek Rác, Ľubomír Skladaný, Adam Szulc, Zuzana Mesárošová, Mária Szántová

  200-210

  2016-12-31
• Genetic implications in patients with NAFLD

  Jakub Misiak, Martyna Kępczyk, Oliwia Kwaśniewska, Michał Urbaś, Miłosz Ojdana, Yehor Demianenko, Oliwia Czekaj, Aleksandra Kościołek, Dawid Kościołek, Kaja Surowiecka

  198-214

  2024-01-19
• Search for a way to improve the serum albumin binding function and the functional state of the liver when hypertension combined with non-alcoholic fatty liver disease

  Yurii Dzordzo, Serhiy Andreychyn

  55-64

  2022-01-11
• Influence of platelet-enriched plasma on the morpho-functional state of liver in rats with induced non-alcoholic steatohepatitis and dyslipidemia

  O. Appelhans, I. Maznichenko, O. Kasatkin, Abdulla Hussein, M. Biriuk, O. Romak

  455-464

  2020-06-30
• Non-invasive diagnostic methods of the liver fibrosis in patients with overweigh and obesity

  Nadiia Gavryliuk, Ihor Hospodarskyy, Oksana Prokopchuk, Olga Namisniak, Mykhailo Havrylyuk

  239-245

  2021-03-31
• Insulin resistance and metabolic diseases - a review

  Marta Drabczyk, Kamila Kosyra, Inga Magda, Zuzanna Marczyńska, Antoni Zyśk

  186-199

  2024-02-19
• Comparative effectiveness of anti-fibrosis treatment in patients after HCV infection and in patients with non-alcoholic fatty liver disease (NAFLD)

  Nadiia Gavryliuk, Ihor Hospodarskyy, Oksana Prokopchuk, Olha Krekhovska-Lepiavko, Borys Lokay, Mykhailo Havrylyuk

  222-229

  2021-02-26
• Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases

  E. F. Chaykivska

  330-353

  2020-01-31
• MAFLD - a new approach to fatty liver disease

  Borys Łozowski, Kinga Brzuszkiewcz-Łozowska, Monika Kułaga, Anna Kasprzak, Monika Grzybek, Diana Mazur-Lesińska, Barbara Szostak, Sylwia Wielgosz-Biała, Krzysztof Tyszkiewicz, Barbara Wilczyńska, Małgorzata Kasprzak

  60039

  2025-05-09
• Pioglitazone - the forgotten drug with multidirectional action

  Arkadiusz Aab, Julia Zarańska

  11-19

  2023-04-25
• Physical activity in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a review of evidence, mechanisms, and practical clinical recommendations

  Maciej Wojewódzki, Małgorzata Styczyńska, Alicja Cyrzan, Jakub Zalewski, Adam Zysk, Mateusz Ząbek, Martyna Iwanowska, Beata Flis, Adrian Goss, Bartosz Fronczak

  69596

  2026-03-12
• Ketogenic diet as a tool in the treatment of diseases

  Natalia Ilnicka, Leila Abod, Daria Matyja, Maria Sadlik, Patrycja Zuziak

  199-203

  2022-11-18
• Innovations in Pharmacotherapy of Diabetes: A Review of Latest Reports

  Katarzyna Czechowska, Aleksandra Świerczewska, Piotr Komasara, Julia Nowakowska, Aleksandra Sędek, Lena Merchel, Ilona Bednarek, Sylwia Lach, Karol Seweryn Błąd, Kinga Kałuża

  61795

  2025-07-08
• Current innovative treatments of obesity

  Damian Wach, Aneta Głaz, Jolanta Wiśniewska, Zuzanna Radziejowska

  227-241

  2023-10-03
• Supplementation of vitamin D in children with obesity and vitamin D deficiency - review of outcomes in terms of obesity parameters and comorbidities

  Weronika Kamińska, Adrian Bobrzyk, Grzegorz Łyko, Maria Antos, Piotr Bator, Angelika Wawryszuk, Maciej Rumian, Weronika Makowska, Krystian Rachwał, Alicja Kosel

  322-332

  2023-08-21
• Modern views on obesity and overweight in individuals after cholecystectomy as prerequisites for the substantiation and development of a physical rehabilitation program

  Natalia Golod

  443-456

  2018-01-31
• Risk factors and comorbidities for psoriatic arthritis. Literature review

  Aleksandra Pich-Czekierda, Zuzanna Kotowicz, Patrycja Proszowska, Adrianna Orzeł , Daria Sieniawska, Magda Madoń, Julia Sieniawska

  49913

  2024-05-14
• The role of curcumin in the management of pain and inflammation across clinical conditions. A narrative review

  Barbara Tomczak, Karolina Klubikowska, Dagmara Porada, Dominika Żukowiecka-Sęga, Wiktoria Tłoczek , Daria Twardowska, Małgorzata Wandzel, Kamil Topolski , Barbara Jelonek , Wiktoria Śliwa

  69388

  2026-03-12
• Impact of soy isoflavones on the prevention and treatment of obesity

  Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś

  21-31

  2024-01-14